179 related articles for article (PubMed ID: 23877403)
1. Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.
Azzazene D; Al Thawadi H; Al Farsi H; Besbes S; Geyl C; Mirshahi S; Pardo J; Faussat AM; Jeannette S; Therwath A; Pujade-Lauraine E; Mirshahi M
Int J Oncol; 2013 Oct; 43(4):1011-8. PubMed ID: 23877403
[TBL] [Abstract][Full Text] [Related]
2. Soluble endothelial protein C receptor (sEPCR) is likely a biomarker of cancer-associated hypercoagulability in human hematologic malignancies.
Ducros E; Mirshahi SS; Faussat AM; Mirshahi P; Dimicoli S; Tang R; Pardo J; Ibrahim J; Marie JP; Therwath A; Soria J; Mirshahi M
Cancer Med; 2012 Oct; 1(2):261-7. PubMed ID: 23342274
[TBL] [Abstract][Full Text] [Related]
3. Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset.
Ducros E; Mirshahi S; Azzazene D; Camilleri-Broët S; Mery E; Al Farsi H; Althawadi H; Besbess S; Chidiac J; Pujade-Lauraine E; Therwath A; Soria J; Mirshahi M
Int J Oncol; 2012 Aug; 41(2):433-40. PubMed ID: 22614534
[TBL] [Abstract][Full Text] [Related]
4. Activated protein C upregulates ovarian cancer cell migration and promotes unclottability of the cancer cell microenvironment.
Althawadi H; Alfarsi H; Besbes S; Mirshahi S; Ducros E; Rafii A; Pocard M; Therwath A; Soria J; Mirshahi M
Oncol Rep; 2015 Aug; 34(2):603-9. PubMed ID: 26082331
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of soluble Endothelial protein C receptor in rheumatoid arthritis and block the therapeutic effect of protein C in collagen-induced arthritis.
Bai L; Liu W; Guo P; Bai J; Liu Y; Hua Y; Pang C; Zhang W; Yin F; Wang Y
Int Immunopharmacol; 2020 Apr; 81():106255. PubMed ID: 32007797
[TBL] [Abstract][Full Text] [Related]
6. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
[TBL] [Abstract][Full Text] [Related]
7. Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma.
Saposnik B; Lesteven E; Lokajczyk A; Esmon CT; Aiach M; Gandrille S
Blood; 2008 Apr; 111(7):3442-51. PubMed ID: 18073349
[TBL] [Abstract][Full Text] [Related]
8. Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis.
Uitte de Willige S; Van Marion V; Rosendaal FR; Vos HL; de Visser MC; Bertina RM
J Thromb Haemost; 2004 Aug; 2(8):1305-10. PubMed ID: 15304035
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Th17 lymphocytes and cytokine IL‑17A in epithelial ovarian tumors.
Winkler I; Pyszniak M; Pogoda K; Semczuk A; Gogacz M; Miotla P; Adamiak A; Darmochwal-Kolarz D; Rechberger T; Tabarkiewicz J
Oncol Rep; 2017 May; 37(5):3107-3115. PubMed ID: 28393233
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function.
Liaw PC; Neuenschwander PF; Smirnov MD; Esmon CT
J Biol Chem; 2000 Feb; 275(8):5447-52. PubMed ID: 10681521
[TBL] [Abstract][Full Text] [Related]
11. Early rise in circulating endothelial protein C receptor correlates with poor outcome in severe sepsis.
Guitton C; Gérard N; Sébille V; Bretonnière C; Zambon O; Villers D; Charreau B
Intensive Care Med; 2011 Jun; 37(6):950-6. PubMed ID: 21394629
[TBL] [Abstract][Full Text] [Related]
12. Suppressive IL-17A
Downs-Canner S; Berkey S; Delgoffe GM; Edwards RP; Curiel T; Odunsi K; Bartlett DL; Obermajer N
Nat Commun; 2017 Mar; 8():14649. PubMed ID: 28290453
[TBL] [Abstract][Full Text] [Related]
13. Triggering receptor expressed on myeloid cells 1 (TREM-1) and cytokine gene variants in complicated and uncomplicated malaria.
Adukpo S; Gyan BA; Ofori MF; Dodoo D; Velavan TP; Meyer CG
Trop Med Int Health; 2016 Dec; 21(12):1592-1601. PubMed ID: 27671831
[TBL] [Abstract][Full Text] [Related]
14. Haplotypes of the endothelial protein C receptor (EPCR) gene are not associated with severe malaria in Tanzania.
Hansson HH; Turner L; Møller L; Wang CW; Minja DT; Gesase S; Mmbando B; Bygbjerg IC; Theander TG; Lusingu JP; Alifrangis M; Lavstsen T
Malar J; 2015 Dec; 14():474. PubMed ID: 26620701
[TBL] [Abstract][Full Text] [Related]
15. Association of soluble endothelial protein C receptor plasma levels and PROCR rs867186 with cardiovascular risk factors and cardiovascular events in coronary artery disease patients: the Athero Gene study.
Kallel C; Cohen W; Saut N; Blankenberg S; Schnabel R; Rupprecht HJ; Bickel C; Munzel T; Tregouet DA; Morange PE
BMC Med Genet; 2012 Nov; 13():103. PubMed ID: 23136988
[TBL] [Abstract][Full Text] [Related]
16. Immune response evaluation through determination of type 1, type 2, and type 17 patterns in patients with epithelial ovarian cancer.
Cândido EB; Silva LM; Carvalho AT; Lamaita RM; Filho RM; Cota BD; da Silva-Filho AL
Reprod Sci; 2013 Jul; 20(7):828-37. PubMed ID: 23239818
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of endothelial protein C receptor respond to anticoagulant treatment.
Stearns-Kurosawa DJ; Swindle K; D'Angelo A; Della Valle P; Fattorini A; Caron N; Grimaux M; Woodhams B; Kurosawa S
Blood; 2002 Jan; 99(2):526-30. PubMed ID: 11781234
[TBL] [Abstract][Full Text] [Related]
18. Soluble endothelial protein C receptor levels and protein C activity in patients with acute ST-segment elevation myocardial infarction.
Tanalp AC; Oduncu V; Erkol A; Gözübüyük G; Ozveren O; Dündar C; Canbay A; Kirma C
Coron Artery Dis; 2013 May; 24(3):209-16. PubMed ID: 23377316
[TBL] [Abstract][Full Text] [Related]
19. The relation between cytokines, soluble endothelial protein C receptor, and factor VIII levels in Turkish pediatric stroke patients.
Yürürer D; Teber S; Deda G; Egin Y; Akar N
Clin Appl Thromb Hemost; 2009 Oct; 15(5):545-51. PubMed ID: 18591180
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis.
Bourke CD; Nausch N; Rujeni N; Appleby LJ; Mitchell KM; Midzi N; Mduluza T; Mutapi F
J Infect Dis; 2013 Jul; 208(1):159-69. PubMed ID: 23045617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
